| Literature DB >> 32252278 |
Marie Ebob Agbortabot Bissong1,2, Collins Njie Ateba1,3.
Abstract
Background: Biofilm formation in S. aureus may reduce the rate of penetration of antibiotics, thereby complicating treatment of infections caused by these bacteria. The aim of this study was to correlate biofilm-forming potentials, antimicrobial resistance, and genes in S. aureus isolates.Entities:
Keywords: Staphylococcus aureus; antimicrobial resistance; biofilm; genes; milk; public health
Year: 2020 PMID: 32252278 PMCID: PMC7235893 DOI: 10.3390/antibiotics9040156
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Distribution of biofilm formation with respect to study location.
| Proportion of Isolates in the Different Biofilm Forming Categories | Location | Total | |||||
|---|---|---|---|---|---|---|---|
| Mafikeng | Rooidepand | Rooigrond | Zeerust | ||||
|
| Moderate | 3 | 1 | 0 | 0 | 4 | |
| None | 3 | 1 | 2 | 1 | 7 | 0.526 | |
| Strong | 27 | 13 | 25 | 1 | 66 | ||
|
| 33 (42.9) | 15 (19.5) | 27 (35.1) | 2 (2.5) | 77 | ||
Figure 1Agarose (1% w/v) gel of the ica gene products of S. aureus isolates. Lane M = DNA marker (100 base pairs DNA Ladder); Lane 1 = icaA amplicon of positive control (S. aureus ATCC 25923); Lane 2 = icaA amplicon of negative control (E. coli ATCC 25922); Lanes 3–6 = icaA amplicons; Lane 10 = icaB amplicons; Lanes 11–14 = icaC amplicons; Lanes 15–19 = icaD amplicons.
Figure 2A dendrogram showing the clustering of biofilm genes based on OD680 of S. aureus isolates (the dendrogram was obtained by using the unweighted paired group method).
Relationship between biofilm formation and biofilm genes in S. aureus isolates.
| Biofilm Formation | Number (%) of Isolates Having the Biofilm Gene | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| None ( | 4 (57.1) | 0 (0.0) | 0 (0.0) | 3 (42.9) | 1 (14.3) |
| Moderate ( | 3 (75.0) | 2 (50) | 3 (75.0) | 4 (100) | 1 (25) |
| Strong ( | 42 (63.6) | 46 (69.7) | 27 (40.9) | 36 (54.5) | 10 (15.1) |
| Total ( | 49 (63.6) | 48 (62.3) | 30 (38.9) | 43 (55.8) | 12 (15.6) |
| 0.777 | 0.027 | 0.259 | 0.674 | 0.084 | |
Figure 3Antimicrobial resistance of S. aureus isolates.
Figure 4A Boxplot of penicillin diameter and blaZ gene (0=blaZ-negative, 1=blaZ-positive).
Correlation between blaZ genes and beta lactamase production.
| Phenotypic Characteristic | Total | |||
|---|---|---|---|---|
| Negative | Positive | |||
| Beta Lactamase Production | Negative | 17 (35.4) | 4 (13.8) | 21 |
| Positive | 31 (64.6) | 25 (86.2) | 56 | |
| Total | 48 | 29 | 77 | |
* Percentages calculated across columns.
Antimicrobial resistance and biofilm profile of MDR S. aureus isolates.
| MDR Isolate | Resistance Phenotype | Biofilm Production | Resistance Genes | Biofilm Genes | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||
|
|
|
|
| |||||||||
| Sum 1 | cef-str-van-oxa | strong | + | - | - | - | - | + | + | + | + | - |
| Ctrl 2 | cef-str-van-oxa | strong | + | + | + | - | - | + | + | + | + | - |
| XWL2 | cef-str-van-oxa | strong | + | + | + | + | - | + | + | + | + | - |
| RPN4L1 | cef-van-oxa | strong | + | - | - | - | - | - | - | - | - | + |
| RPN4L2 | cef-van-oxa | strong | + | + | - | - | - | + | + | + | - | - |
| RPN21 | cef-oxa-cip-chl | none | - | + | + | + | - | - | - | - | - | + |
| RPN3 | str-van-oxa-tet | strong | + | + | + | + | - | + | + | + | + | - |
| SUM 2 | cef-str-van-oxa | strong | + | - | + | - | - | + | + | + | + | - |
| RPN2L | cef-van-oxa-tet-chl | strong | - | - | - | - | - | + | + | + | + | - |
| RPN1L | cef-van-oxa | strong | + | - | - | - | - | + | - | - | - | - |
| RPN30 | cef-ery-str-van-lev-oxa-tet | strong | + | + | + | + | + | - | + | - | - | - |
| Fa1L | cef-ery-van-oxa-tet | moderate | - | - | + | + | - | - | - | - | - | + |
| Fa2S | cef-str-van-sul-lev-oxa-cip-chl | strong | - | - | - | - | - | - | + | - | - | - |
| Bb1LY2 | cef-van-oxa | strong | - | - | - | - | - | - | - | - | - | - |
| LIC3M | cef-van-oxa-cip-chl | strong | + | + | - | - | - | + | + | - | + | - |
| XY | cef-van-oxa | strong | + | + | + | + | - | - | - | - | - | + |
| LIC 1 | str-van-oxa-tet | strong | - | + | + | + | - | - | - | - | - | + |
| LIC 2M | cef-str-van | strong | - | - | - | - | - | + | + | - | + | - |
| KE18 | cef-oxa-tet | strong | - | - | + | + | + | - | - | - | - | - |
| K5 | cef-van-oxa | strong | + | + | + | + | - | + | + | - | + | - |
| K9 | cef-van-oxa | strong | - | - | - | - | + | + | + | - | + | - |
| K10 | cef-van-oxa | strong | + | - | - | - | - | + | + | - | + | - |
| K11 | cef-van-oxa | strong | + | + | + | + | - | - | + | - | + | - |
| K85 | cef-van-oxa | strong | + | + | - | - | - | + | + | + | + | - |
| K87 | cef-van-oxa | moderate | + | + | - | - | + | + | - | - | + | - |
Putative virulence and resistance genes and primer sequences used in this study.
| Gene | Primer Sequence | Amplicon Size (bp) | Reference |
|---|---|---|---|
|
| F-GCGATTGATGGTGGATACGGT | 279 | [ |
|
| F-ACACTTGCTGGCGCAGTCAA | 188 | [ |
|
| F-AGAATCGTGAAGTATAGAAAATT | 900 | [ |
|
| F-ATGGGACGGATTCCATGAAAAAGA | 1075 | [ |
|
| F-ATGGTCAAGCCCAGACAGAG | 198 | [ |
|
| F-CCCTATATCGAAGGTGTAGAATTGCAC | 971 | [ |
|
| F-CAAAGATGATATAGTTGCTTATTCTCC | 421 | [ |
|
| F-GTAGCGACAATAGGTAATAGT | 360 | [ |
|
| F-GTCGTTGCGCGCTATATTCC | 696 | [ |
|
| F-AGTATCATTAATCACTAGTGC | 367 | [ |
|
| F-CGATGAAGGAGGATTAAAATG | 1733 | [ |
|
| F-ATGAATAGAATAAAAGTTGC | 1032 | [ |
|
| F-GTGACAAACCGGAGGCGAGGA | 430 | [ |